Estimating the Impact of Medical Innovation: A Case Study of HIV Antiretroviral Treatments
---- Acknowledgements -----
This work was supported by grants from the Robert Wood Johnson Foundation (Duggan), the Alfred P. Sloan Foundation (Duggan), the National Science Foundation (Evans), and the Maryland Population Research Center. We thank Julian Cristia, Tami Hayford, Scott Imberman, Victor Macias, and Daniel Perlman for outstanding research assistance and Jim Klein from the California Department of Health Services for assistance with the Medicaid data. We are also grateful to David Autor, Dana Goldman, Michael Greenstone, Steven Levitt, Frank Lichtenberg, Justin McCrary, Catherine Wolfram, and seminar participants at the Brookings Institution, the Centers for Medicare and Medicaid Services, University of California at Berkeley, University of Chicago, Columbia University, RAND, Rochester University, Stanford University, the World Bank, and the NBER Health Care meetings for helpful suggestions. The views expressed in this paper are those of the authors and not necessarily those of any of the individuals or institutions mentioned above. All errors are our own.